Introduction No data are available on the diagnostic role of biomarkers in angina/ischemia with non-obstructive coronary artery disease (ANOCA/INOCA); therefore, we aimed to identify clinical and circulating biomarkers associated with ANOCA/INOCA versus acute and chronic coronary syndrome (ACS-CCS). Methods In this single-center study, consecutive patients with ANOCA/INOCA were prospectively enrolled and compared with a historical cohort of patients with ACS and CCS. Blood samples were collected to measure circulating endothelin-1 (ET-1), soluble urokinase-type plasminogen activator receptor, cardiac troponin I (TnI), C-reactive protein, cystatin C (Cys-C), and neuropeptide Y. Clinical characteristics and circulating biomarkers were compared across groups, and multinomial logistic regression was performed to identify independent predictors of ANOCA/INOCA. Results Between April 2023 and February 2024, 102 ANOCA/INOCA patients were enrolled and compared with patients with ACS (n=101) or CCS (n=40). Female sex was more prevalent in ANOCA/INOCA vs. other groups. Significant differences in biomarker levels were observed for: ET-1, TnI, and Cys-C. In multivariable multinomial logistic regression, low TnI levels and female sex were independently associated with ANOCA/INOCA versus ACS (OR, 0.84; 95% CI, 0.78–0.91; p<0.001; OR, 3.90; 95% CI, 1.25–12.16; p=0.019, respectively) and CCS (OR, 0.88; 95% CI, 0.82–0.95; p=0.001; OR, 11.05; 95% CI, 3.43–35.57; p<0.001). Higher Cys-C levels were associated with ANOCA/INOCA versus CCS only (OR, 1.53; 95% CI, 1.11–2.10; p=0.010). Conclusions Patients with ANOCA/INOCA exhibited a distinct biomarker profile compared with ACS and CCS. Female sex and lower TnI levels emerging as independent predictors of ANOCA/INOCA compared with ACS and CCS, and higher Cys-C levels additionally associated with ANOCA/INOCA compared with CCS.

Biomarker Profiling Across Angina/Ischemia with Non-Obstructive Coronary Artery Disease: A Subanalysis of the BIOPLATINO Study.

STROSIO, MICHELE
2024/2025

Abstract

Introduction No data are available on the diagnostic role of biomarkers in angina/ischemia with non-obstructive coronary artery disease (ANOCA/INOCA); therefore, we aimed to identify clinical and circulating biomarkers associated with ANOCA/INOCA versus acute and chronic coronary syndrome (ACS-CCS). Methods In this single-center study, consecutive patients with ANOCA/INOCA were prospectively enrolled and compared with a historical cohort of patients with ACS and CCS. Blood samples were collected to measure circulating endothelin-1 (ET-1), soluble urokinase-type plasminogen activator receptor, cardiac troponin I (TnI), C-reactive protein, cystatin C (Cys-C), and neuropeptide Y. Clinical characteristics and circulating biomarkers were compared across groups, and multinomial logistic regression was performed to identify independent predictors of ANOCA/INOCA. Results Between April 2023 and February 2024, 102 ANOCA/INOCA patients were enrolled and compared with patients with ACS (n=101) or CCS (n=40). Female sex was more prevalent in ANOCA/INOCA vs. other groups. Significant differences in biomarker levels were observed for: ET-1, TnI, and Cys-C. In multivariable multinomial logistic regression, low TnI levels and female sex were independently associated with ANOCA/INOCA versus ACS (OR, 0.84; 95% CI, 0.78–0.91; p<0.001; OR, 3.90; 95% CI, 1.25–12.16; p=0.019, respectively) and CCS (OR, 0.88; 95% CI, 0.82–0.95; p=0.001; OR, 11.05; 95% CI, 3.43–35.57; p<0.001). Higher Cys-C levels were associated with ANOCA/INOCA versus CCS only (OR, 1.53; 95% CI, 1.11–2.10; p=0.010). Conclusions Patients with ANOCA/INOCA exhibited a distinct biomarker profile compared with ACS and CCS. Female sex and lower TnI levels emerging as independent predictors of ANOCA/INOCA compared with ACS and CCS, and higher Cys-C levels additionally associated with ANOCA/INOCA compared with CCS.
2024
Biomarker Profiling Across Angina/Ischemia with Non-Obstructive Coronary Artery Disease: A Subanalysis of the BIOPLATINO Study.
Biomarkers
ANOCA
INOCA
Troponin
Cystatin-C
File in questo prodotto:
File Dimensione Formato  
Tesi MICHELE STROSIO.pdf

Accesso riservato

Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/120697